Sawsan A. Zaitone
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Papers in
- Pharmacology 18
- Co-authors
- Yasser M. Moustafa (22 shared papers)Nehal M. Elsherbiny (12 shared papers)Dina M. Abo‐Elmatty (5 shared papers)Noha M. Abogresha (3 shared papers)Eman Said (4 shared papers)Mohamed K. El-Kherbetawy (13 shared papers)Noha E. Farag (10 shared papers)Mohamed El‐Sherbiny (11 shared papers)
- Journals
- Pharmaceuticals (9 papers)Life Sciences (8 papers)Biomedicine & Pharmacotherapy (6 papers)Frontiers in Pharmacology (6 papers)Pharmacological Reports (4 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Sawsan A. Zaitone
113 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Pharmacology 182
- Complementary and alternative medicine 169
- Geriatrics and Gerontology 71
- Pharmaceutical Science 102
- Pharmacology 267
Countries citing papers authored by Sawsan A. Zaitone
This map shows the geographic impact of Sawsan A. Zaitone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sawsan A. Zaitone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sawsan A. Zaitone more than expected).
Fields of papers citing papers by Sawsan A. Zaitone
This network shows the impact of papers produced by Sawsan A. Zaitone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sawsan A. Zaitone. The network helps show where Sawsan A. Zaitone may publish in the future.
Co-authors
The 25 scholars most cited alongside Sawsan A. Zaitone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 115 | |
| 2 | 2018 | 96 | |
| 3 | 2012 | 74 | |
| 4 | 2019 | 65 | |
| 5 | 2012 | 64 | |
| 6 | 2017 | 63 | |
| 7 | 2011 | 55 | |
| 8 | 2020 | 54 | |
| 9 | 2014 | 52 | |
| 10 | 2020 | 50 | |
| 11 | 2015 | 47 | |
| 12 | 2018 | 41 | |
| 13 | 2021 | 41 | |
| 14 | 2020 | 40 | |
| 15 | 2018 | 38 | |
| 16 | 2015 | 38 | |
| 17 | 2015 | 36 | |
| 18 | 2022 | 36 | |
| 19 | 2018 | 34 | |
| 20 | 2015 | 32 |
About Sawsan A. Zaitone
Sawsan A. Zaitone is a scholar working on Molecular Biology, Pharmacology, Oncology, Organic Chemistry and Endocrinology, Diabetes and Metabolism, having authored 119 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (7 papers), Retinal Diseases and Treatments (6 papers), Synthesis and biological activity (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). The work is most often cited by research in Pharmacology (182 citations), Complementary and alternative medicine (169 citations), Geriatrics and Gerontology (71 citations), Pharmaceutical Science (102 citations) and Pharmacology (267 citations). Sawsan A. Zaitone has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Yasser M. Moustafa, Nehal M. Elsherbiny, Dina M. Abo‐Elmatty, Noha M. Abogresha, Eman Said, Mohamed K. El-Kherbetawy, Noha E. Farag, Mohamed El‐Sherbiny, Hala M.F. Mohammad and Eman T. Mehanna. Their work appears in journals such as Pharmaceuticals, Life Sciences, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology and Pharmacological Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.